MYC and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell disorder dependent on MYC expression and driven by the activated tyrosine kinase activity of the BCR-ABL1 fusion protein [185,186,187].